Eletriptan Hydrobromide
16 NDCs across 7 manufacturers|11 Generic,5 Brand
Eletriptan Hydrobromide is used to treat migraine disorders, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 26, 2002, and the first generic was approved Jun 16, 2017. FDA's Orange Book lists 16 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $9 million on Eletriptan Hydrobromide across 70,000 claims for 17,000 beneficiaries.
Eletriptan Hydrobromide is available as 16 NDCs from 7 manufacturers (11 generic, 5 brand), with NADAC prices from $1.73 to $77.43 per EA — the most expensive product costs about 45× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
16
11G / 5B
Manufacturers
7
competing in market
Price Spread
$1.73 – $77.43
per EA
7d Activity
avg -7.5% WoW · of 16 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Viatris Specialty LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Serotonin-1b and Serotonin-1d Receptor Agonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
7 manufacturers producing ELETRIPTAN HYDROBROMIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
RELPAX 20 MG TABLET | $77.4338 per EA | — |
RELPAX 20 MG TABLET | $77.3705 per EA | -0.08% |
RELPAX 40 MG TABLET | $77.1444 per EA | — |
RELPAX 40 MG TABLET | $77.0487 per EA | -0.04% |
RELPAX 40 MG TABLET | $77.0487 per EA | -0.04% |
ELETRIPTAN HBR 40 MG TABLET | $1.7451 per EA | -8.59% |
ELETRIPTAN HBR 40 MG TABLET | $1.7451 per EA | -8.59% |
ELETRIPTAN HBR 40 MG TABLET | $1.7451 per EA | -8.59% |
ELETRIPTAN HBR 40 MG TABLET | $1.7451 per EA | -8.59% |
ELETRIPTAN HBR 40 MG TABLET | $1.7451 per EA | -8.59% |
ELETRIPTAN HBR 40 MG TABLET | $1.7451 per EA | -8.59% |
ELETRIPTAN HBR 20 MG TABLET | $1.7293 per EA | -10.65% |
ELETRIPTAN HBR 20 MG TABLET | $1.7293 per EA | -10.65% |
ELETRIPTAN HBR 20 MG TABLET | $1.7293 per EA | -10.65% |
ELETRIPTAN HBR 20 MG TABLET | $1.7293 per EA | -10.65% |
ELETRIPTAN HBR 20 MG TABLET | $1.7293 per EA | -10.65% |
Frequently Asked Questions
What is Eletriptan Hydrobromide used to treat?
Eletriptan Hydrobromide is used to treat migraine disorders, per the National Library of Medicine's MED-RT classification.
When did Eletriptan Hydrobromide become available as a generic?
FDA approved the first generic Eletriptan Hydrobromide (ANDA) on Jun 16, 2017. The Orange Book currently lists 16 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Eletriptan Hydrobromide?
In 2024, Medicare Part D spent $9 million on Eletriptan Hydrobromide across 70,000 claims for 17,000 beneficiaries.
How many Eletriptan Hydrobromide products are on the market?
The Eletriptan Hydrobromide drug market contains 16 NDCs from 7 manufacturers — 11 generic and 5 brand products.
What is the price range for Eletriptan Hydrobromide?
NADAC reference prices for Eletriptan Hydrobromide range from $1.7293 to $77.4338 per EA — the most expensive product costs about 45× the cheapest.
Is generic Eletriptan Hydrobromide cheaper than brand?
The average generic NADAC for Eletriptan Hydrobromide is $1.7379 per EA, versus $77.2092 for brand-labeled products — brand versions average about 44× the generic price.
Which manufacturers make Eletriptan Hydrobromide?
7 manufacturers list Eletriptan Hydrobromide in NADAC. Ranked by number of NDCs, the largest are Viatris Specialty LLC (3), Mylan Pharmaceuticals Inc. (3), Roerig (2), Aurobindo Pharma Limited (2), Camber Pharmaceuticals Inc. (2).
How has the price of Eletriptan Hydrobromide changed recently?
Over the past 7 days, 0 Eletriptan Hydrobromide NDCs rose and 14 fell, with a market-wide average change of -7.5%.